IS SECOND LINE SYSTEMIC CHEMOTHERAPY BENEFICIAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)? : A MULTICENTER DATA EVALUATION OF ANATOLIAN SOCIETY OF MEDICAL ONCOLOGY (ASMO) - (:unkn) unknown (LIPPINCOTT WILLIAMS & WILKINS, 2013)
Keywords: prognostic factors; survival; non-small cell lung cancer; second line treatment